Bleeding events in COVID-19: the other side of the coin?
We present three cases of patients affected by severe SARS-CoV-2-related pneumonia treated with a low molecular weight heparin for prevention or treatment of pulmonary embolism, who presented a major bleed, in particular an ileopsoas haematoma that caused severe anaemia; in one case it was fatal. In the recent outbreak of novel coronavirus infection, significantly abnormal coagulation parameters in SARS-CoV-2 infection occur very often, but complications in the opposite direction such as bleeding diathesis are very rare. In these cases, there are different levels of gravity: for one patient the major bleed required the anticoagulant therapy to be stopped until bleeding stabilized, one patient needed interventional radiology and one patient died.PMID:33794592 | DOI:10.4081/monaldi.2021.1739
Source: Monaldi Archives for Chest Disease - Category: Respiratory Medicine Authors: Antonietta Coppola Anna Annunziata Maria Rosaria Gioia Giuseppe Fiorentino Source Type: research
More News: Anemia | Bleeding | Coronavirus | COVID-19 | Outbreaks | Pneumonia | Pulmonary Thromboembolism | Radiology | Respiratory Medicine | SARS